Sign in

CIK 0001714899

  • Large accelerated filer

Denali Therapeutics Inc.

Sign in to watch
Ticker
DNLI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
463872213
Phone
+1 650-866-8547
Business address
161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Open-market sale CFO and Treasurer sold 1,428 shares at $19.48 ($27,817)
  9. 4 Open-market sale COO and Secretary sold 1,427 shares at $19.49 ($27,812)
  10. 4 Open-market sale Chief Medical Officer sold 1,428 shares at $19.48 ($27,817)
  11. 4 Open-market sale President and CEO sold 4,807 shares at $19.48 ($93,640)
  12. 4/A Exercise or conversion CFO and Treasurer acquired 4,250 shares (option exercise)
  13. 4/A Exercise or conversion COO and Secretary acquired 4,250 shares (option exercise)
  14. 4/A Exercise or conversion Chief Medical Officer acquired 4,250 shares (option exercise)
  15. 4/A Exercise or conversion President and CEO acquired 14,315 shares (option exercise)
  16. 4 Open-market sale 10% owner sold 3,894,764 shares at $20.25 ($78,868,971)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 16 of 22 · 436 filings